Effects of glutathione on antioxidant response element-mediated gene expression and apoptosis elicited by

Bok-Ryang Kim1, Rong Hu, Young-Sam Keum

  • 1Department of Pharmaceutics, Ernest Mario School of Pharmacy, Rutgers, The State University of New Jersey, 160 Frelinghuysen Road, Piscataway, New Jersey 08854, USA.

Cancer Research
|November 13, 2003
PubMed

Insights

Reduced glutathione (GSH) plays a key role in sulforaphane (SFN)-induced gene expression and apoptosis. Adding GSH blocks SFN

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Cell Biology

Background:

  • Sulforaphane (SFN) and its N-acetyl-L-cysteine (NAC) conjugate inhibit tumorigenesis by inducing antioxidant response element (ARE)-related genes and apoptosis.
  • Reduced glutathione (GSH) is crucial for cellular defense mechanisms and redox homeostasis.

Purpose of the Study:

  • To investigate the role of GSH in SFN- and SFN-NAC-induced ARE-mediated gene expression, apoptosis, and c-Jun NH(2)-terminal kinase (JNK) activation in HepG2-C8 cells.
  • To elucidate the differential effects of SFN and SFN-NAC on these cellular processes and the influence of extracellular GSH.

Main Methods:

  • HepG2-C8 cells were treated with varying concentrations of SFN and SFN-NAC.
  • Cellular GSH levels, ARE-mediated gene expression, caspase 3 activity, and JNK1/2 activation were measured.
  • Cells were pretreated with L-buthionine sulfoximine or supplemented with extracellular GSH to assess GSH's role.

Main Results:

  • SFN caused a transient decrease followed by a significant increase in cellular GSH levels, while SFN-NAC had minimal impact.
  • SFN induced ARE expression more potently than SFN-NAC, an effect enhanced by L-buthionine sulfoximine.
  • Extracellular GSH addition blocked SFN-induced ARE expression and JNK1/2 activation, and reduced SFN-induced apoptosis.
  • Higher concentrations of SFN and SFN-NAC correlated with increased apoptosis and caspase 3 activation.

Conclusions:

  • SFN and SFN-NAC exhibit distinct mechanisms in modulating ARE-related gene expression and apoptosis.
  • Cellular GSH levels are critical for mediating the biological effects of SFN.
  • The pro-apoptotic and gene-regulatory effects of SFN are significantly influenced and can be inhibited by GSH.

Related Concept Videos

Phase II Reactions: Glutathione Conjugation and Mercapturic Acid Formation01:22

Phase II Reactions: Glutathione Conjugation and Mercapturic Acid Formation

Glutathione, a tripeptide made up of glutamate, cysteine, and glycine, is a critical player in the detoxification of drugs and xenobiotics via a process known as glutathione conjugation or mercapturic acid formation. This phase II biotransformation reaction involves the covalent binding of glutathione to a drug or its metabolite, enhancing the compound's water solubility and enabling its excretion.
Several distinctive characteristics distinguish glutathione conjugation from other phase II...
Sulfur Assimilation01:20

Sulfur Assimilation

Sulfur is an essential element in biological systems, contributing to synthesizing key biomolecules, including amino acids such as cysteine and methionine, and cofactors such as coenzyme A and biotin. Microorganisms primarily assimilate sulfur as sulfate (SO₄²⁻) from the environment, which must undergo a series of biochemical transformations before it can be incorporated into cellular components. As sulfate is highly oxidized, it must undergo assimilatory sulfate reduction to become...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...